Height and Alzheimer's disease: findings from a case-control study.

The purpose of this study is to examine the relationship of height, Apolipoprotein E genotype (APOE) and Alzheimer's disease (AD). Using a case-control design, subjects were recruited from the research registry of the University Memory and Aging Center of Case Western Reserve University and University Hospitals of Cleveland. On entry to the study, height was measured on 239 probable or possible AD patients and 341 healthy controls living in northeast Ohio.

[Neuropsychiatric symptoms in dementias: preliminary report of a prospective outpatient evaluation in Brazil].

This study aimed to evaluate the behavioral and psychological symptoms in dementia (BPSD) and to correlate the level of the functional dependence, cognitive decline and neuropsychiatric symptoms in outpatients. In this prospective study, 35 elderly with dementia (DSM-IV) were evaluated over the course of one year with the Mini-Mental State Examination (MMSE), Clinical Dementia Rating Scale (CDR), Neuropsychiatric Inventory (NPI) and Functional Activities Questionnaire (FAQ). Spearman correlation was used to compare cognitive, functional and behavioral symptoms in the first and last visits.